ArticleJournal of nanobiotechnology2026

A NIR-Ⅱ-Immunostimulatory nanoplatform rewires immunometabolism to unleash STING-driven antitumor immunity.

Xun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.